HDFC SILVER ETF FUND OF…₹38.974.29% TATA SILVER ETF FUND OF…₹30.924.27% DSP SILVER ETF₹24.524.18% NIPPON INDIA SILVER ETF₹35.924.16% UTI SILVER ETF₹30.164.15% MIRAE ASSET SILVER ETF₹10.514.11% SBI SILVER ETF₹25.144.07% ZERODHA SILVER ETF₹21.504.05% ADITYA BIRLA SUN LIFE S…₹36.604.03% GROWW SILVER ETF₹22.873.98% HDFC SILVER ETF FUND OF…₹38.974.29% TATA SILVER ETF FUND OF…₹30.924.27% DSP SILVER ETF₹24.524.18% NIPPON INDIA SILVER ETF₹35.924.16% UTI SILVER ETF₹30.164.15% MIRAE ASSET SILVER ETF₹10.514.11% SBI SILVER ETF₹25.144.07% ZERODHA SILVER ETF₹21.504.05% ADITYA BIRLA SUN LIFE S…₹36.604.03% GROWW SILVER ETF₹22.873.98%
GFS GFSGayatri Financial Synergy
/
Client Login
GFS » Mutual Fund » Sectoral / Thematic » UTI Healthcare Fund
Published NAVNAV published by the AMC, sourced from AMFI
62.09177.87293.65409.441 Aug 201620 Aug 2026
Change+300.5%change over the window — not annualised
Low / high₹80.70 / ₹390.8310 Oct 2019 · 11 Aug 2026
Last print-0.12%19 Aug 2026 → 20 Aug 2026
Prints1,119published NAVs, AMFI · axis does not start at zero

Returns

NAV and returns as at 20 Aug 2026
Lumpsum · point to point
1W -0.39%
1M +1.86%
3M +9.53%
6M +21.72%
YTD +20.15%
1Y +16.36%
2Y CAGR +13.2%
3Y CAGR +24.04%
5Y CAGR +16.79%
10Y CAGR +14.93%
SIP · XIRR on monthly instalments
6M SIP +56.69%
1Y SIP +31.83%
2Y SIP +19.02%
3Y SIP +21.12%
5Y SIP +22.23%
10Y SIP +19.74%
Full history SIP +19.74%
Periods up to one year are absolute; longer periods are annualised (CAGR). SIP figures are the XIRR of a fixed monthly instalment over the same window. — means this scheme’s NAV history does not cover that period — across all 1648 schemes, 68% have a 3-year figure, 48.8% a 5-year one, and 32.7% a 10-year one.

Returns vs category

1Y
This fund
+16.36%
Sectoral / Thematic avg
+9.11%
3Y
This fund
+24.04%
Sectoral / Thematic avg
+17.01%
5Y
This fund
+16.79%
Sectoral / Thematic avg
+14.93%
Average is the mean of every Sectoral/ Thematic scheme in this dataset that discloses the period — 216 schemes at 1Y, 126 at 3Y, 94 at 5Y. Returns beyond one year are annualised.

Top holdings

as at 31 Jul 2026 · source: AMC monthly portfolio disclosure
EQ - SUN PHARMACEUTICALS INDUSTRIESPharmaceuticals & Biotechnology 8.71%
EQ - DIVIS LABORATORIES LTD.Pharmaceuticals & Biotechnology 5.57%
EQ - AJANTA PHARMA LTD.Pharmaceuticals & Biotechnology 4.8%
EQ - CAPLIN POINT LABORATORIES LTDPharmaceuticals & Biotechnology 3.95%
EQ - LUPIN LTD.Pharmaceuticals & Biotechnology 3.59%
EQ - GLAND PHARMA LTD.Pharmaceuticals & Biotechnology 3.56%
EQ - APOLLO HOSPITALS ENTERPRISE LTHealthcare Services 3.46%
EQ - DR REDDYS LABORATORIES LTD.Pharmaceuticals & Biotechnology 3.1%
EQ - ALKEM LABORATORIES LTDPharmaceuticals & Biotechnology 3.1%
EQ- GLOBAL HEALTH LTD.Healthcare Services 2.81%
Top 10 42.65%Securities 44Securities total 97.06%Cash & equivalents 2.92%
The ten largest securities by weight, out of 44 disclosed. Weight is percent of net assets as filed. Cash-equivalent lines (TREPS, reverse repo, net receivables, margin) and derivative legs are counted in the chips above but not ranked among securities, because a short futures leg is filed as a negative weight and sorting it alongside a shareholding describes no portfolio. A portfolio is a point-in-time filing and changes every month.

Risk

Volatility · annualised · 3Y
14.76%
Max drawdown · 3Y
-15.88%
Sharpe ratio
1.15
SEBI riskometer
Very High
Volatility is the annualised standard deviation of daily NAV moves over the last three years; max drawdown is the deepest peak-to-trough fall in that same window. Where a scheme has less than three years of NAV, the window is what it actually has and is labelled as such — never as three years. Sharpe is as disclosed in the scheme key-ratio feed (as at 24 July 2026).
Beta and alpha are not shown. No benchmark series in the source.

Cost

Expense ratio1.28%
Category average1.73%
Exit load1%
52W high / low₹390.8277 / ₹304.4841
Expense ratio 1.28% vs a category average of 1.73% — 0.45 percentage points lower. Among Sectoral/ Thematic schemes disclosing an expense ratio it is 110th of 166, cheapest first.
Expense ratio and category average are as disclosed against this scheme in the source; 78.5% of schemes here carry one. The ratio is charged inside the NAV, so every return on this page is already net of it.

Scheme facts

SEBI sub-category Sectoral/ Thematic
Plan / option Direct Growth
Benchmark BSE Health Care - TRI
Fund manager Kamal Gada
Launched 27 May 1999
NAV history here 10.0y
ISIN INF789F01TO9
AMFI scheme code 120782
SEBI riskometer Very High
Exit load 1%
Lock-in None
Minimum lumpsum ₹5,000
Exit load, as disclosed: 1% on or before 30D · Nil after 30D
Not shown on this page, and why
Star ratingGFS is an AMFI-registered distributor (ARN-169480), not a SEBI-registered investment adviser. It does not rate schemes.
Scheme AUMScheme-level AUM is not in the source; only AMC-total AUM, which is a different number.
Minimum SIPNot present in the source.
Beta and alphaNo benchmark series in the source.

General SIP calculator

A general SIP illustration: your monthly amount grown at the annual rate you set below, compounded monthly. The rate is your assumption — it is not this scheme’s past return, not a forecast of it, and mutual fund returns are not assured.
Monthly SIP₹10,000
Tenure10 years
Assumed annual return12%
Invested₹12,00,000
Est. gain₹11,23,391
Total value₹23,23,391